Citius Oncology GAAP EPS of -$0.08 beats by $0.11, revenue of $1.5M misses by $4.27M — See source for full details.
$CTOR
Price history, market instrument context, member research, and related headlines in one place.
CTOR key statistics
NasdaqCMUSD
52-week range
$0.49114%$2.25
Latest session $0.7451–$0.7699Citius Oncology, Inc. (CTOR) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $0.746, down $0.01 (1.43%) from the previous close of $0.7568. It has traded between $0.7451 and $0.7699 in the latest session. Over the past year it has ranged from $0.491 to $2.25, leaving it in the lower quarter of its 52-week range (14%). Reported volume for the session was 11K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Loading $CTOR research…